<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-118623</identifier>
<setSpec>0211-139X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prevalence of metabolic syndrome in elderly patients</dc:title>
<dc:description xml:lang="en">Objectives. To determine the prevalence of metabolic syndrome (MS) according to the definitions of the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) and the International Diabetes Federation (IDF) and its relation to cardiovascular disease (CVD) in hospitalized elderly patients. Material and methods. This descriptive and prospective study (February-March 2011) included 200 consecutive patients hospitalized in a Geriatric Department. Sociodemographic, clinical and biochemical data was collected. Results. The prevalence of MS was 65% (NCEP-ATP III) and 67.5% (IDF) and was greater in women (NCEP-ATP III=72.8%, IDF=73.6%) than in men (NCEP-ATP III=50.7%; IDF=56.3%). The mean age of patients diagnosed with MS by both diagnostic criteria were similar: 84.7 years. MS was not associated with an increased prevalence of CVD. Conclusions. MS is highly prevalent in elderly hospitalized patients, being higher in women, with both diagnostic criteria (NCEP- ATP III and IDF). In our population the MS was not associated with an increased prevalence of CVD (AU)</dc:description>
<dc:creator>Bonafonte Marteles, José Luis</dc:creator>
<dc:creator>Morlanes Navarro, Teresa</dc:creator>
<dc:creator>Calvo Gracia, Fernando</dc:creator>
<dc:creator>Quílez Pina, Raquel María</dc:creator>
<dc:creator>Castro Vilela, María Elena</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivos. Conocer la prevalencia del síndrome metabólico (SM) según las definiciones del National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III ) y la International Diabetes Federation (IDF) y su relación con la enfermedad cardiovascular (ECV) en los ancianos hospitalizados. Material y método. Estudio descriptivo, prospectivo realizado entre febrero y marzo del 2011. Se estudiaron 200 pacientes consecutivos hospitalizados. Se registraron las variables sociodemográficas, clínicas, bioquímicas y antecedentes personales. Resultados. La prevalencia del SM fue del 65% (NCEP-ATP III ) y 67,5% (IDF), siendo mayor en las mujeres (NCEP-ATP III  = 72,8%; IDF = 73,6%), que en los varones (NCEP-ATP III  = 50,7%; IDF = 56,3%). La edad media de los pacientes diagnosticados de SM según ambos criterios diagnósticos fue parecido: 84,7 años. El SM no se asoció a una mayor prevalencia de ECV. Conclusiones. El SM tiene una elevada prevalencia en los ancianos hospitalizados, siendo mayor en mujeres, tanto con los criterios NCEP-ATP III como con los de la IDF. En nuestra población el SM no se asoció a una mayor prevalencia de ECV (AU)</dc:description>
<dc:source>Rev. esp. geriatr. gerontol. (Ed. impr.);49(1): 20-23, ene.-feb. 2014.</dc:source>
<dc:identifier>ibc-118623</dc:identifier>
<dc:title xml:lang="es">Prevalencia del síndrome metabólico en los ancianos hospitalizados</dc:title>
<dc:subject>^d3942^s22080</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d27295</dc:subject>
<dc:subject>^d36032^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d55111^s22031</dc:subject>
<dc:subject>^d36032^s22054</dc:subject>
<dc:subject>^d7130^s22054</dc:subject>
<dc:subject>^d14679</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d3942^s22054</dc:subject>
<dc:subject>^d7130^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>201402</dc:date>
</metadata>
</record>
</ibecs-document>
